missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CRISP-1 Rat anti-Mouse, Clone: 840017, R&D Systems™

Rat Monoclonal Antibody
Brand: R&D Systems MAB4675-SP
This item is not returnable.
View return policy
Description
CRISP-1 Monoclonal specifically detects CRISP-1 in Mouse samples. It is validated for Western Blot, Immunohistochemistry, Neutralization.Specifications
| CRISP-1 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Acidic epididymal glycoprotein homolog, acidic epididymal glycoprotein-like 1, AEGL1, AEG-related protein, ARPAEG-like protein, CRISP1, CRISP-1AEGL1HSCRISP1D, cysteine-rich secretory protein 1, cysteine-rich secretory protein-1 delta, HSCRISP1G, HUMARP | |
| Rat | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 167 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
| Western Blot, Immunohistochemistry, Neutralization | |
| 840017 | |
| Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Neutralization 10-20 ug/mL | |
| Q03401 | |
| Crisp1 | |
| Mouse myeloma cell line NS0-derived recombinant mouse CRISP-1 Gln20-His244 Accession # Q03401 | |
| 25 μg | |
| Primary | |
| Detects mouse CRISP-1 in direct ELISAs. | |
| Mouse | |
| Purified |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction